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ABSTRACT
Multiple studies characterizing the human ageing
phenotype have been conducted for decades. How-
ever, there is no centralized resource in which data on
multiple age-related changes are collated. Currently,
researchers must consult several sources, including
primary publications, in order to obtain age-related
data at various levels. To address this and facilitate
integrative, system-level studies of ageing we devel-
oped the Digital Ageing Atlas (DAA). The DAA is a
one-stop collection of human age-related data cov-
ering different biological levels (molecular, cellular,
physiological, psychological and pathological) that
is freely available online (http://ageing-map.org/).
Each of the >3000 age-related changes is associated
with a specific tissue and has its own page display-
ing a variety of information, including at least one
reference. Age-related changes can also be linked
to each other in hierarchical trees to represent dif-
ferent types of relationships. In addition, we devel-
oped an intuitive and user-friendly interface that al-
lows searching, browsing and retrieving information
in an integrated and interactive fashion. Overall, the
DAA offers a new approach to systemizing ageing
resources, providing a manually-curated and readily
accessible source of age-related changes.
INTRODUCTION
Ageing can be defined as a progressive functional decline, or
a gradual deterioration of physiological function with age,
often including a decrease in fecundity (1). Human ageing
is characterized by multiple changes at different levels of bi-
ological organization (2,3). It is still not clear which (if any)
molecular, cellular or physiological changes are more im-
portant drivers of the process of ageing or how they influ-
ence each other. One difficulty in understanding how differ-
ent processes at different scales relate to ageing as a whole
is the lack of integrative, holistic views of ageing. This hin-
ders studies of how different molecular, cellular and physio-
logical components interact with each other, in spite of the
recognized importance of such approaches (4,5).
Particularly now in the post-genome era, efforts to ob-
tain a more comprehensive and detailed characterization
of molecular changes with ageing, such as those using
-omics approaches (6–8), have been widespread. Use of this
quantitative data, including its meta- and re-analysis, al-
lows the application of systems biology approaches to age-
ing research. Consequently, there is now a drive to link
these molecular level changes to cellular and physiologi-
cal processes. The ultimate aim is to elucidate how molecu-
lar changes with age, for example, may influence or are in-
fluenced by changes in the wider organism, e.g. hormonal
changes, and ultimately how these interactions contribute
to pathology. Nonetheless, collating and converting raw
data into information that is usable and can be cross com-
pared is time consuming and difficult. In this context, we de-
veloped the Digital Ageing Atlas (DAA; http://ageing-map.
org/), the first portal encompassing age-related changes at
different biological levels, including a large amount of -
omics data, already processed, categorized and filtered for
statistical significance.
DIGITAL AGEING ATLAS CONTENT, INTERFACE AND
STRUCTURE
Conceptually, an age-related change represents an observed
difference of a molecule, parameter or process between
young and old, and various and diverse types of properties
can be represented in a quantitative and/or qualitative way.
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Table 1. The number of human age-related changes for each category in the Digital Ageing Atlas
Type of change Description Number of changes
Molecular Changes with age of a molecular nature, most being gene-centric 3071 (2599 genes)
Physiological All non-molecular physiological ageing changes 343
Psychological Cognitive and behaviour changes with age 17
Pathological Changes in disease incidence or mortality for age-related diseases 95
To catalogue and organize age-related changes, in the DAA
they fall into four broad categories: molecular, physiologi-
cal, psychological and pathological changes (Table 1). The
DAA contains: more than 3000 molecular ageing changes,
which include gene expression, epigenetic and proteomic
changes; over 300 physiological changes, which include cel-
lular, hormonal and changes at various scales (including or-
gans and the whole organism); and psychological or cogni-
tive changes. Also included are pathological changes, list-
ing epidemiological data on the incidence and/or mortality
of major age-related diseases. Our focus is on changes oc-
curring during normal ageing across populations, though
e.g. gender-specific changes are indicated. As detailed be-
low, data was manually-curated from the literature, such as
textbooks and papers, and retrieved from public databases
like GEO (9). All changes are fully referenced making it pos-
sible to access the raw data. In total, the DAA currently de-
tails 3526 biological changes in humans and 713 changes
in mice. The DAA focuses on human data, however mouse
data has been included, in particular gene expression data,
and cross-linked to relevant human entries (e.g., homolo-
gous genes), to enhance and expand the information on hu-
man ageing. We anticipate the addition of data from other
model organisms in the future.
Presenting information in an easy-to-understand visual
form is a powerful means of fostering the analysis and in-
terpretation of large datasets and of allowing researchers to
identify gaps in knowledge and develop new research direc-
tions (10,11). Without it the comprehension of large-scale
or diverse datasets is impeded. Therefore, not only does
the DAA merge different types of data into a single repos-
itory, but we developed an intuitive and user-friendly web
resource that allows accessing, searching, browsing and re-
trieving the datasets in an integrated and interactive fash-
ion. Specifically, we developed an anatomical diagram to
allow users to browse and select their organ of interest (Fig-
ure 1). The use of keyword term searching (e.g. ‘heart’ will
show both tissues and changes associated with the heart
while ‘p53’ will show changes related to any gene with p53
in its name or alias) and more general anatomical selection
offers a great deal of flexibility to users, ensuring that users
of any level of technical skill can access the resources, in-
cluding non-researchers, opening up the field of ageing to a
wider audience.
Each age-related change in the DAA has its own page dis-
playing a variety of information. Typically, entries include
a description of the change with age, a quantification (if
available) of the change with age (e.g. a percentage gene ex-
pression change between two ages), at least one reference
and relevant links (Figure 2). The way in which the changes
are stored in the database is best described in an object-
orientated way. The key objects in the DAA are change, tis-
Figure 1. The DAA anatomical model. Moving the mouse over a given
organ reveals the number of age-related changes in the DAA, along with a
breakdown of the number of each specific type of change. Colours indicate
the number of changes for each change type (orange: physiological, red:
pathological, blue: molecular, green: psychological).
sue, gene, property and data. The change object stores the
basic information on a change including type, age of oc-
currence, gender (if available) and organism. The gene ob-
ject contains basic information on a gene, e.g. symbol and
name, mapping to other information such as homologues
in other organisms, Gene Ontology (GO) terms and links to
external resources, for instance cross-linking to the GenAge
database of ageing-related genes (12) (Figure 3). Gene in-
formation can then be associated with multiple changes to
prevent repetition and ensure ease of updating when ele-
ments such as the gene symbol change. It also allows for the
DAA to display all changes associated with a gene making
it easier to find information. The tissue object contains de-
tails on a tissue such as a name and description. The tissue
objects (currently 284 different tissues are represented) are
arranged into a simple hierarchical structure, based upon
the ontology created by eVOContology (13), supplemented
by descriptive data from both Brenda (14) and Wikipedia
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Figure 2. A labelled diagram of the entry for IGF1 age-related changes in the plasma: (1) Each change is colour coded for easy identification of type.
(2) As all changes are assigned to a tissue it is easy to see the different changes occurring on an organ level. (3) Each change is fully referenced allowing
for additional details into the methodology and access to the original data. (4) Clear identification of the amount and direction of change with age
(if applicable) is provided, along with how it was derived. (5) Changes can be stored persistently between sessions as well as compared on-site using the
graphing functionality. (6) Descriptions provide more details, including greater clarification regarding the context in which the change was observed and/or
measured. (7) Linking changes to genes allows, much like linking tissues, the ability to see all the changes associated with a particular gene.
(http://en.wikipedia.org) and further expanded in our lab.
Each tissue has a parent and zero or more children. The root
parent represents the whole organism and the tissue hierar-
chy can be navigated on our interface. Each change is asso-
ciated with one or more tissues, allowing for exploration of
the number and types of changes occurring in each tissue or
organ.
The property object allows for non-duplicate properties
to be defined and associated with changes (e.g. the loca-
tion property may take values like synapse, mitochondria,
cellular, etc). These properties are defined by the curators
and can encompass any value which may be relevant to the
change but is not recorded elsewhere. This allows for great
flexibility in recording type-specific information (e.g. sub-
cellular location) and can be filtered against in the search
interface. The data object allows the association of specific
types of data with a change. It is divided into sub-objects
that cover a class of data, such as percentage, equation or
dataset. These store specific sets of data with some fields
such as ‘change measured’ common between all. Percent-
age objects store a simple percentage value; equation objects
store the components of an equation describing the change
in a quantitative fashion; dataset objects store an arbitrary
number of data points to plot more fragmentary data such
as mortality rates. With this the database can cover most
types of data that can be associated with a change during
the life course, and more can be easily added, if required,
with very little effort. These data are presented on the details
page and used for the display of increase/decrease icons on
the search page, among others.
The relationship object stands alone as it is not directly
related to a change. Instead, similar to the tissue object, it
stores a hierarchical representation of information. Each re-
lationship object is linked to a single change and option-
ally another relationship object. These are then chained
together to create a tree. Multiple trees can be associated
with a change and can describe different types of associ-
ations from causal relationships to similar processes that
are occurring together. Linking the relationship objects to
changes allows the construction of complex hierarchies of-
ten encompassing different biological levels while still per-
mitting a given change to appear in multiple hierarchies.
A change can appear in multiple trees as the change may
be a part of multiple processes, some of which may not
be closely related. A good example of this is DAA982
(which refers to changes in CD16 expression in the elderly)
in which there are two trees describing how the gene (a
molecular change) reacts during two distinct physiologi-
cal ageing changes. Relationships also link pathologies to
physiological and molecular changes associated with them,
like for Alzheimer’s disease (DAA615) which is associated
with neuritic plaques (DAA723) and beta-amyloid deposits
(DAA1996).
Interpretation and visualization of the data is facilitated
by tools built into the DAA. Any numerical change within
the DAA can be compared against others by adding them to
a list which can then be analysed in a graph form within the
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Figure 3. The details page for the gene GH1. This shows the two ageing changes associated with it and the links to external resources including GO terms,
orthologs and various other databases.
website. For example, a comparison can be made of molec-
ular changes presented in graph form allowing the compari-
son of the gene expression levels recorded by those changes
(Figure 4). More complex analyses can be performed us-
ing external tools as the DAA permits downloading both
through its export tool and through the availability of the
complete DAA dataset for download. The export tool itself
takes advantage of the search and filtering supported and
allows for specific subsets of data to be extracted and saved
as a tab-delimited text file. The DAA and all its data is made
available under a permissive licence.
DATA SELECTION AND CURATION
Data in the DAA is manually curated and each age-related
change has been selected based upon clearly defined crite-
ria. First, only age-related changes for which there is direct,
empirical evidence supported by one or more references are
included. Second, only ageing changes occurring in vivo are
incorporated into the DAA. Since our goal is to define typ-
ical age-related changes, we focused on those observed dur-
ing healthy ageing, with the obvious exception of patho-
logical age-related changes that describe mortality and in-
cidence rates of specific diseases of the aged. Although the
goal is to make the DAA as complete as possible, the focus is
on what are likely the most important age-related changes,
which in many cases are the changes that are also involved
in determining age-related pathologies. Negative results can
be included if these are deemed relevant to understand age-
ing, e.g. DAA711 refers to measurements of heart physiol-
ogy that are unchanged with age. Our general policy regard-
ing conflicting reports is to cite all conflicting reports and let
users make their own decisions on how to interpret them.
Molecular changes (e.g. gene expression, protein lev-
els and methylation) from high-throughput approaches are
usually selected based on criteria for statistical significance
that the authors have used in the sourced data, though
data and methods (e.g. correction for multiple hypothesis
testing) are examined as part of our QC procedures which
are described in de Magalhães et al. (6). A P-value cut-off
of 0.001 or lower is normally used for genome-wide ap-
proaches. This value was reached based on standard prac-
tice and observation of effects of the data and ensures that
the changes added are above the noise threshold. Ours is an
inclusive policy, however, and effect sizes and P-values are
included in the DAA to allow users to make their own deci-
sions about which data is relevant. The primary sources of
data for the molecular section have been the meta-analysis
by de Magalhães et al. (6), public databases like GEO (9)
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Figure 4. Storing changes for later analysis. A combination of two screenshots showing how changes can be added to the saved list and then compared
against each other using the graphing capabilities of the Digital Ageing Atlas. Filters allow for a narrowing of results based on the properties of each
change; Multiple filters can be applied. The actions column provides the ability to add and remove changes to the stored list.
and primary publications. Therefore, quantitative data can
be taken directly from publications or recomputed as in (6)
with the specific type of equation used indicated in the de-
tails page for a given entry. At the time of writing the DAA
includes 24 datasets from high throughput screens (mainly
microarrays) that cover 22 different tissues.
Physiological changes were sourced from books (2,3,15),
reviews and primary publications. Major changes in cell
populations are likely to contribute to age-related physio-
logical and pathological changes, therefore studies of cel-
lular alterations with age are included, but results from in
vitro cellular models of ageing are not included in the DAA.
Pathological and some physiological changes were sourced
from the Centers for Disease Control and Prevention
(CDC) (http://www.cdc.gov/nchs/hdi.htm), selected based
on their relevance to chronic ageing conditions and the ages
which they cover. Psychological changes were sourced from
the same locations as the physiological changes with the
condition that they must indicate a change in behaviour or
cognition as the organism ages.
Ageing changes vary between individuals and popula-
tions. It is not the goal of the DAA to capture the indi-
vidual diversity of age-related changes and thus the rel-
ative dependence on large datasets. The objective of the
DAA is to provide an overview of major age-related changes
and so typical values are featured, though outliers are in-
dicated in notes-specific to each data type. For example,
gender-specific changes are featured and properly anno-
tated. An attempt is made to obtain data from consis-
tent sources. In mice, age-related changes and even lifespan
can vary between strains, therefore the C57BL/6 strain is
used as the ‘gold standard’ in the case of conflicting find-
ings, however discrepancies are highlighted when they oc-
cur. The C57BL/6 strain was selected because, currently, it
is the most commonly used mouse strain for ageing studies.
This strategy is consistent with other similar projects like
AGEMAP (16) and the Allen Brain Atlas (17) that also fo-
cus on the C57BL/6 strain. If age-related changes are sus-
pected of being population-specific, then this is indicated in
the DAA through a specific property.
The site itself uses the Python-based Django framework
and is served by an Nginx web server. It uses PostgreSQL
9.1 as a database backend, implementing a number of con-
straints to ensure entries are not duplicated or left as or-
phans when a change instance is deleted. A web-based cu-
ration application was also created that allows for easy addi-
tion and updating of data without requiring knowledge of
the technical operations of the portal. We encourage con-
tributions by the wider research community. By having an
intuitive and easily usable curation interface this provides
the ability to both quickly correct and add relevant infor-
mation as well as allowing specialists to directly contribute
D878 Nucleic Acids Research, 2015, Vol. 43, Database issue
to its improvement, thus ensuring that it stays at the fore-
front of ageing research.
AVAILABILITY
The DAA is available at http://ageing-map.org with the data
made available under the permissive Creative Commons li-
cence, allowing data to be used in other analyses. There are
options to either download the entire database or to down-
load more focused data using the export tool. Feedback via
email is welcome, as are submissions of new data, for which
a submission form is provided to ensure that the relevant
information is included.
CONCLUSION
The DAA is an integrated web resource for studying and
visualizing human age-associated changes at various bio-
logical levels. It can aid researchers to perform integrative,
system-level analysis of ageing. While target users are pri-
marily fundamental researchers, it is anticipated that the
DAA will also be useful to clinicians, students and the pub-
lic in general. Other existing ageing-related resources such
as GenAge (12), AgeFactDB (18) and SAGEWEB (http:
//sageweb.org/) focus on genes and factors that alter lifespan
and/or ageing. By providing a manually-curated and read-
ily accessible source of age-related changes during the nor-
mal life course, the DAA is thus complementary to existing
resources and offers a new approach to systemizing ageing
resources. This brings numerous benefits, limiting duplica-
tion of efforts and maintaining the accuracy of data which
is essential given the rapid pace at which the field of age-
ing is progressing. In conclusion, the DAA aims to become
the most comprehensive source for data related to ageing
changes, consistently providing high-quality data, covering
a wide variety of different biological levels.
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Human ageing genomic resources: integrated databases and tools for
the biology and genetics of ageing. Nucleic Acids Res. 41,
D1027–D1033.
13. Kruger,A., Hofmann,O., Carninci,P., Hayashizaki,Y. and Hide,W.
(2007) Simplified ontologies allowing comparison of developmental
mammalian gene expression. Genome Biol. 8, R229.
14. Gremse,M., Chang,A., Schomburg,I., Grote,A., Scheer,M.,
Ebeling,C. and Schomburg,D. (2011) The BRENDA Tissue Ontology
(BTO): the first all-integrating ontology of all organisms for enzyme
sources. Nucleic Acids Res., 39, D507–D513.
15. Whitbourne,S. K. (1985) The Aging Body: Physiological Changes and
Psychological Consequences. Springer-Verlag, NY.
16. Zahn,J. M., Poosala,S., Owen,A. B., Ingram,D. K., Lustig,A.,
Carter,A., Weeraratna,A. T., Taub,D. D., Gorospe,M.,
Mazan-Mamczarz,K. et al. (2007) AGEMAP: a gene expression
database for aging in mice. PLoS Genet. 3, e201.
17. Sunkin,S. M., Ng,L., Lau,C., Dolbeare,T., Gilbert,T. L.,
Thompson,C. L., Hawrylycz,M. and Dang,C. (2012) Allen Brain
Atlas: an integrated spatio-temporal portal for exploring the central
nervous system. Nucleic Acids Res. 41, D996–D1008.
18. Hühne,R., Thalheim,T. and Sühnel,J. (2014) AgeFactDB-the JenAge
ageing factor database-towards data integration in ageing research.
Nucleic Acids Res. 42, D892–D896.
